The Negative Efficacy of COVID-19 mRNA Injections Has Been Demonstrated

Four studies establish that 'vaccinated' individuals ultimately face a higher risk of infection compared to those who are not.

by Nicolas Hulscher, MPH

STUDY #1 - Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland

Key Finding - Among individuals vaccinated, the odds of reinfection are 1.42 times higher (42% higher) for those who received 2 or more doses compared to those with 1 dose or less (95% CI: 1.13–1.78):

---

STUDY #2 - Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar

Key Findings - The effectiveness of the BNT162b2 (Pfizer-BioNTech) injection against symptomatic BA.1 and BA.2 Omicron infections declined from 46.6% and 51.7%, respectively, within 1–3 months after the second dose to -17.8% and -12.1% at 7 months or later. Similarly, the effectiveness of the mRNA-1273 (Moderna) injection declined from 71.0% and 35.9%, respectively, within 1–3 months after the second dose to -10.2% and -20.4% at 7 months or later​:

---

STUDY #3 (Cleveland Clinic) - Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine

Key Findings - The risk of COVID-19 increased with the number of vaccine doses previously received:

• 1 dose: HR = 2.07 (95% CI: 1.70–2.52)
  Individuals with one prior dose had a 107% increased risk of COVID-19 compared to those with no prior doses.

• 2 doses: HR = 2.50 (95% CI: 2.17–2.89)
  Individuals with two prior doses had a 150% increased risk of COVID-19 compared to those with no prior doses.

• 3 doses: HR = 3.10 (95% CI: 2.69–3.56)
  Individuals with three prior doses had a 210% increased risk of COVID-19 compared to those with no prior doses.

• More than 3 doses: HR = 3.53 (95% CI: 2.97–4.20)
  Individuals with more than three prior doses had a 253% increased risk of COVID-19 compared to those with no prior doses.

---

STUDY #4 (Centers for Disease Control and Prevention) - Protection from COVID-19 vaccination and prior SARS-CoV-2 infection among children aged 6 months – 4 years, United States, September 2022–April 2023

Key Findings - Children vaccinated with Pfizer-BioNTech without prior SARS-CoV-2 infection were 159% more likely to get infected and 257% more likely to develop symptomatic COVID-19 compared to unvaccinated children without prior infection:

• Hazard Ratio (HR) for infection: 2.59 (95% CI: 1.27–5.28).

• HR for symptomatic COVID-19: 3.57 (95% CI: 1.10–11.63).

---

Abundant evidence of negative efficacy, excess mortality, and DNA contamination provides clear and indisputable grounds for the immediate withdrawal of COVID-19 mRNA injections from global markets to safeguard public health.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.